Literature DB >> 8840998

Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis.

R A Lothe1, R Karhu, N Mandahl, F Mertens, G Saeter, S Heim, A L Borresen-Dale, O P Kallioniemi.   

Abstract

The genetic changes leading to the development of malignant peripheral nerve sheath tumors (MPNSTs) are largely unknown. The few tumors that have been investigated cytogenetically had highly complex karyotypes and no consistent rearrangements, and the attempts to pinpoint consistent DNA-level changes have met with only limited success. We used comparative genomic hybridization to analyze seven MPNSTs and one dermatofibrosarcoma protuberans from eight patients with von Recklinghausen's disease (neurofibromatosis type 1), as well as three sporadic MPNSTs. Gains and losses of DNA sequences were found in all tumors, with an average of four losses (range, 0-14) and two gains (range, 0-5) per tumor. Two striking observations were made: (a) an increase in copy number of the distal part of the long arm of chromosome 17, with the smallest region of overlap 17q24-qter, was seen in five of seven MPNSTs and in the only dermatofibrosarcoma protuberans, all of which were from patients with neurofibromatosis, whereas none of the three sporadic MPNSTs had this alteration; and (b) loss of 13q, with the smallest region of overlap 13q14-q21, was found in 6 of 10 MPNSTs. The consistent involvement of these two chromosomal regions probably reflects two different pathogenetic mechanisms for MPNSTs.

Entities:  

Mesh:

Year:  1996        PMID: 8840998

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Authors:  G P Nielsen; A O Stemmer-Rachamimov; Y Ino; M B Moller; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.

Authors:  Gill Spurlock; Samantha J L Knight; Nick Thomas; Tim-Rasmus Kiehl; Abhijit Guha; Meena Upadhyaya
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-15       Impact factor: 4.553

4.  Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

Authors:  Syed J Kazmi; Stephanie J Byer; Jenell M Eckert; Amy N Turk; Richard P H Huijbregts; Nicole M Brossier; William E Grizzle; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Am J Pathol       Date:  2013-01-13       Impact factor: 4.307

5.  Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Authors:  Helge R Brekke; Matthias Kolberg; Rolf I Skotheim; Kirsten S Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; Håvard E Danielsen; Fredrik Mertens; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2009-01-30       Impact factor: 12.300

6.  Loss of Y chromosome in the malignant peripheral nerve sheet tumor of a patient with Neurofibromatosis type 1.

Authors:  Seon-Yong Jeong; Sang-Jin Park; Su-Jin Lee; Ho-Jin Park; Hyon J Kim
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

Review 7.  The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.

Authors:  Steven L Carroll
Journal:  Am J Pathol       Date:  2015-12-28       Impact factor: 4.307

8.  Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.

Authors:  Eric P Rahrmann; Branden S Moriarity; George M Otto; Adrienne L Watson; Kwangmin Choi; Margaret H Collins; Margaret Wallace; Beau R Webber; Colleen L Forster; Anthony E Rizzardi; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Am J Pathol       Date:  2014-05-13       Impact factor: 4.307

9.  Oncogenicity of the developmental transcription factor Sox9.

Authors:  Ander Matheu; Manuel Collado; Clare Wise; Lorea Manterola; Lina Cekaite; Angela J Tye; Marta Canamero; Luis Bujanda; Andreas Schedl; Kathryn S E Cheah; Rolf I Skotheim; Ragnhild A Lothe; Adolfo López de Munain; James Briscoe; Manuel Serrano; Robin Lovell-Badge
Journal:  Cancer Res       Date:  2012-01-13       Impact factor: 12.701

10.  Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.

Authors:  Eric P Rahrmann; Adrienne L Watson; Vincent W Keng; Kwangmin Choi; Branden S Moriarity; Dominic A Beckmann; Natalie K Wolf; Aaron Sarver; Margaret H Collins; Christopher L Moertel; Margaret R Wallace; Bernat Gel; Eduard Serra; Nancy Ratner; David A Largaespada
Journal:  Nat Genet       Date:  2013-05-19       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.